AAIC Presentation Highlights Improved Efficacy and Safety With Lecanemab Subcutaneous Autoinjector
New findings reveal the promising efficacy and safety of a subcutaneous lecanemab autoinjector for early Alzheimer disease treatment, enhancing patient care.